• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

The choice of whether to stop or continue ADHD medications during breastfeeding and pregnancy is challenging for women with the condition. Little data exists about how long-term exposure to these medications can affect the fetus.

A recent study published in Molecular Psychiatry shows that children exposed to ADHD medication during the uterus do not develop neurological developmental disorders like hearing loss or impaired vision seizures, febrile seizures, or IQ impairment. The authors acknowledge the need for higher-quality studies.

Risk/Benefit Analysis

Women who are expecting and taking ADHD medication should consider the benefits of taking it against the potential risks to the foetus. The doctors don't have the information to give clear advice however they can provide information about risks and benefits to help pregnant women make informed decisions.

A study published in Molecular Psychiatry found that women who were taking ADHD medications during early pregnancy did not have an increased risk of fetal cardiac malformations or major structural birth defects. Researchers conducted a large, population-based case-control study to determine the prevalence of major structural birth defects in infants born to mothers who had taken stimulants in the early stages of pregnancy and those who had not. Clinical geneticists and pediatric cardiologists examined the cases to ensure an accurate classification of the cases and to reduce the chance of bias.

However, the researchers' study was not without its flaws. The researchers were unable in the beginning to distinguish the effects caused by the medication from the disorder. This makes it difficult to know whether the small associations observed in the exposed groups result from medication use or comorbidities that cause confusion. Researchers also did not examine long-term outcomes for the offspring.

over the counter adhd medication uk study showed that infants whose mothers took ADHD medication during pregnancy had a greater risk of being admitted to the neonatal care unit (NICU) as compared to those whose mothers did not use any medication during pregnancy, or had discontinued taking their medication prior to or during pregnancy. This increase was caused by central nervous system disorders. The increased risk of admission was not influenced by the stimulant medications used during pregnancy.

Women who were taking stimulant ADHD medications during pregnancy also had a higher risk of having to have an emergency caesarean section or having a baby that scored low on the Apgar scale (less than 7). These risks did not appear to be influenced by the type of medication that was used during pregnancy.

Researchers suggest that the minor risks posed by the use of ADHD medications in early pregnancies can be offset by more beneficial outcomes for both baby and mother of continued treatment for the woman's condition. Physicians should talk Where to get prescribed adhd medication their patients about this issue and as much as possible, assist them improve coping skills which can lessen the effects of her disorder on her daily life and relationships.

Medication Interactions

As more women than ever before are being diagnosed with ADHD and treated with medication, the issue of whether or not to stop treatment during pregnancy is a question that doctors are having to confront. Most of the time, these decisions are made in the absence of solid and reliable evidence either way, so physicians must weigh their knowledge about their experiences, the experiences of other doctors, and what the research says on the topic as well as their best judgment for each patient.

Particularly, the issue of possible risks to the baby can be a challenge. The research on this issue is based on observation rather than controlled studies and a lot of the results are contradictory. Additionally, the majority of studies limit their analysis to live births, which could underestimate severe teratogenic effects that lead to abortion or termination of the pregnancy. The study discussed in this journal club addresses these shortcomings by looking at data from both live and deceased births.

The conclusion: While some studies have shown an association between ADHD medications and the risk of certain birth defects, others have found no such relationship, and most studies demonstrate a neutral or slight negative effect. In the end, a careful risk/benefit assessment must be done in each situation.

It can be difficult, if not impossible for women suffering from ADHD to stop taking their medication. In fact, in an article recently published in Archives of Women's Mental Health psychologist Jennifer Russell notes that stopping ADHD medication during pregnancy can cause depression, feelings of loneliness and family conflict for those suffering from the disorder. A loss of medication may affect the ability to safely drive and to perform work-related tasks which are essential aspects of everyday life for people dealing with adhd without medication ADHD.

She suggests women who are uncertain about whether or where to Get prescribed adhd medication not to discontinue medication due to their pregnancy, consider informing family members, friends, and coworkers on the condition, its impact on daily functioning, and the advantages of staying on the current treatment plan. Educating them can also aid in ensuring that the woman feels supported as she struggles with her decision. Certain medications can be passed through the placenta. If the patient decides not to take her ADHD medication while pregnant and breastfeeding, it is crucial to be aware that the drug could be transferred to the baby.

Risk of Birth Defects

As the use of ADHD drugs to treat symptoms of attention deficit hyperactivity disorder (ADHD) increases as do concerns about what impact the drugs might have on fetuses. Recent research published in the journal Molecular Psychiatry has added to the body of knowledge on this issue. Researchers utilized two massive data sets to study more than 4.3 million pregnant women and determine if stimulant medication use caused birth defects. While the overall risk remains low, the scientists did find that first-trimester exposure to ADHD medications was linked to a slightly higher rate of certain heart defects, such as ventriculoseptal defect (VSD).

The researchers of the study found no association between early medication use and other congenital anomalies, such as facial clefting or club foot. The results are in the same vein as previous studies which showed a small, but significant increase in the number of cardiac malformations among women who started taking ADHD medication before the birth of their child. The risk was higher during the latter part of pregnancy, when many women begin to discontinue their medication.

Women who used ADHD medications in the first trimester of their pregnancies were also more likely to have caesarean section, low Apgar score after delivery and a baby that required breathing assistance during birth. The researchers of the study were not able to eliminate selection bias because they limited the study to women who did not have any other medical conditions that might have contributed to the findings.

The researchers hope that their research will aid in the clinical decisions of physicians who see pregnant women. They recommend that, while a discussion of the benefits and risks is important but the decision to stop or maintain treatment must be based on each woman's requirements and the severity of her ADHD symptoms.

The authors also caution that while discontinuing the medications is an option, it is not a recommended practice because of the high prevalence of depression and other mental health issues for women who are expecting or who are recently post-partum. Additionally, research suggests that women who stop taking their medications will have a tough adjustment to life without them after the baby is born.

Nursing

It can be a challenge to become a mom. Women suffering from ADHD can face severe challenges when they must manage their symptoms, go to doctor appointments, prepare for the birth of a child and adjust to new routines. Many women opt to continue taking their ADHD medication during pregnancy.

The majority of stimulant medicines pass through breast milk in low quantities, so the risk to nursing infant is very low. However, the frequency of medication exposure to the newborn may differ based on dosage, frequency it is administered, and the time of the day the medication is administered. In addition, different medications are introduced into the baby's system via the gastrointestinal tract or through breast milk. The impact of these medications on the health of a newborn isn't fully known.

Some doctors may decide to stop stimulant medications during a woman's pregnancy due to the absence of research. It is a difficult decision for the mother, who must weigh the benefits of taking her medication as well as the potential risks to the foetus. In the meantime, until more information is available, GPs can inquire about pregnant patients if they have an history of ADHD or if they intend to take medication during the perinatal stage.

Numerous studies have demonstrated that women can continue taking their ADHD medication without risk during pregnancy and while breast-feeding. As a result, more and more patients choose to do so and in consultation with their physician, they have found that the benefits of maintaining their current medication outweigh any potential risks.

It is crucial for women suffering from ADHD who are thinking of breastfeeding to seek a specialist psychiatrist's advice prior to becoming pregnant. They should discuss their medication with their physician and discuss the advantages and disadvantages of continued treatment, including non amphetamine adhd medication-pharmacological strategies. Psychoeducation is also required to help pregnant women suffering from ADHD be aware of the symptoms and the underlying disorder. They should also be educated about treatment options and strengthen coping mechanisms. This should be a multidisciplinary approach, which includes the GP as well as obstetricians, psychiatry and obstetricians. The pregnancy counselling should consist of the discussion of a plan for management for both the mother as well as the child, monitoring for signs of deterioration and when necessary, making adjustments to the medication regimen.